Myriad Genetics Inc (MYGN)

Capital Expenditure

-$2.10M

Quarterly · Period ending: · USD

MYGN logo

MYGN Capital Expenditure

Latest reported-$2.10M
MYGN Quarterly CapEx (-$2.20M → -$2.10M)
High-resolution chart · PNG

MYGN capital expenditure history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Myriad Genetics Inc Capital Expenditure — Quarterly (USD)
Period endingCapital Expenditure (USD)
-1,230,299
-1,407,582
-1,236,182
-1,381,150
-1,163,196
-1,854,000
-700,000
-900,000
-600,000
-1,500,000
-900,000
-1,000,000
-1,100,000
-700,000
-700,000
-700,000
-700,000
-1,400,000
-1,000,000
-1,600,000
-1,000,000
-2,200,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.